Toyota Boshoku, Autoneum, and Nihon Tokushu Toryo Agree to Establish Joint Venture
With an aim to further strengthen the ongoing cooperative relationship in automobile interior business, Toyota Boshoku Corporation (TOKYO:3116), Autoneum (CH0127480363) and Nihon Tokushu Toryo Co., Ltd. (TOKYO:4619) have signed a joint venture agreement to undertake noise and vibration (NV) evaluation and analysis of automobile interior systems.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171004005065/en/
Toyota Boshoku is a leading company that develops and manufactures complete automobile interior systems, while Autoneum and Nihon Tokushu Toryo have the world’s highest level of acoustic technologies in the field of soundproof automotive components. In 2012, the three parties agreed to establish a cooperative relationship in automobile interior business. Since then, the parties have deepened business collaboration to address various challenges by leveraging their specific expertise.
The parties have agreed to establish a joint venture in the beginning of 2018 in order to further deepen their ongoing cooperative business relationship. Using the buildings and equipment of Toyota Boshoku’s Oguchi Plant, the new company will be engaged in NV evaluation and analysis of automobile interior and exterior systems for Toyota Motor Corporation and other automotive related companies, along with advanced development of the systems. The new company will merge the parties’ high level of technological development capabilities so that it will be entrusted with NV evaluation and analysis based on manufacturers’ trust.
As an organization that continually proposes and provides superior automobile interior systems to our customers throughout the world, Toyota Boshoku will make every effort to provide our customers with excellent interior spaces under the concept of “QUALITY OF TIME AND SPACE” in all aspects of human mobility. In particular, we will strengthen our automobile interior system development capability by strengthening the technical cooperative relationship between the three parties in NV evaluation and analysis.
Overview of new company
|1.||Company name||ATN Auto Acoustics Inc.|
|2.||Location||Aichi-prefecture, Japan (Toyota Boshoku’s Oguchi plant)|
|3.||Establishment||In the beginning of 2018|
|5.||Investment ratio||Toyota Boshoku 49%, Nihon Tokushu Toryo 26%, Autoneum 25%|
|6.||Executives||Toyota Boshoku 2, Nihon Tokushu Toryo 1, Autoneum 1|
|7.||Employees||Start with about 10 members, and strengthen according to business scale|
|8.||Content of business||NV evaluation and analysis of automobile interior and exterior systems, along with advanced development of the systems.|
About Toyota Boshoku group
Toyota Boshoku group , one of the world’s premier interior system suppliers and filter manufacturers, develops and produces interior components, filtration and powertrain components at over 100 sites in 27 countries around the world. During the fiscal period ending in March 2017, Toyota Boshoku had consolidated net sales of 1,358 billion yen (approx. $12 billion) and operating income of 72 billion yen (approx. $640 million).
TOYOTA BOSHOKU CORPORATION
Mariko Suzuki, +81-566-26-0301
External Affairs & Public Relations div.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
HEIDELBERG-ENGINEERING21.9.2018 18:43 | pressemeddelelse
Heidelberg Engineering Announces the CE-Marking of ANTERION
JEDOX21.9.2018 17:48 | pressemeddelelse
Florian Winterstein Becomes New CEO of Jedox
AVINOR21.9.2018 16:39 | pressemeddelelse
Avinor to Test Autonomous Snowploughs at Oslo Airport This Winter
MA-TAKEDA-PHARMACEUTICAL21.9.2018 15:32 | pressemeddelelse
Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib
HCL-TECHNOLOGIES21.9.2018 14:18 | pressemeddelelse
Asda Selects HCL Technologies to Help Drive IT Transformation
IPSEN21.9.2018 07:32 | pressemeddelelse
Ipsen Receives Positive CHMP Opinion for Cabometyx® (Cabozantinib) for the Second-line Treatment of Patients with Hepatocellular Carcinoma (HCC)
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum